CIK 0001590877
- Non-accelerated filer
- Smaller reporting company
REGENXBIO Inc.
Sign in to watch- Ticker
- RGNX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 471851754
- Phone
- +1 240-552-8181
- Business address
- 9804 MEDICAL CENTER DRIVE, ROCKVILLE, MD, 20850
- Former names
- ReGenX Biosciences, LLC
- Open-market buys, last 90 days
- $949,381
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$949,381. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2018-08-15 | Vasista Vittal Chief Financial Officer | Sale | −1,301 | $65.99 | $86K | 122,283 |
| 2018-07-16 | Vasista Vittal Chief Financial Officer | Sale | −2,628 | $74.19 | $195K | 134,655 |
| 2018-07-16 | Vasista Vittal Chief Financial Officer | Sale | −2,510 | $75.18 | $189K | 132,145 |
| 2018-07-16 | Vasista Vittal Chief Financial Officer | Sale | −862 | $76.60 | $66K | 131,283 |
| 2018-07-16 | Vasista Vittal Chief Financial Officer | Sale | −1,500 | $77.88 | $117K | 129,783 |
| 2018-06-20 | Mills Kenneth T. President and CEO | Sale | −200 | $61.70 | $12K | 208,330 |
| 2018-06-20 | Mills Kenneth T. President and CEO | Sale | −100 | $63.45 | $6K | 208,230 |
| 2018-06-20 | Mills Kenneth T. President and CEO | Sale | −1,300 | $65.48 | $85K | 206,930 |
| 2018-06-20 | Mills Kenneth T. President and CEO | Sale | −2,650 | $66.59 | $176K | 204,280 |
| 2018-06-20 | Mills Kenneth T. President and CEO | Sale | −750 | $67.66 | $51K | 203,530 |
| 2018-06-19 | Christmas Patrick J. SVP, General Counsel | Exercise or conversion | +1,528 | $12.10 | $18K | 17,669 |
| 2018-06-19 | Christmas Patrick J. SVP, General Counsel | Exercise or conversion · Employee Stock Option (Right to Buy) | −1,528 | 68,472 | ||
| 2018-06-18 | Christmas Patrick J. SVP, General Counsel | Exercise or conversion | +5,000 | $12.10 | $61K | 21,141 |
| 2018-06-18 | Christmas Patrick J. SVP, General Counsel | Sale | −400 | $55.25 | $22K | 20,741 |
| 2018-06-18 | Christmas Patrick J. SVP, General Counsel | Sale | −4,600 | $56.91 | $262K | 16,141 |
| 2018-06-18 | Christmas Patrick J. SVP, General Counsel | Exercise or conversion · Employee Stock Option (Right to Buy) | −5,000 | 70,000 | ||
| 2018-06-15 | Vasista Vittal Chief Financial Officer | Sale | −3,157 | $56.20 | $177K | 141,626 |
| 2018-06-15 | Vasista Vittal Chief Financial Officer | Sale | −4,343 | $56.90 | $247K | 137,283 |
| 2018-06-05 | HAYDEN DONALD J JR Director | Exercise or conversion | +14,900 | $0.85 | $13K | 14,900 |
| 2018-06-05 | HAYDEN DONALD J JR Director | Sale | −14,900 | $55.01 | $820K | 0 |
Page 40 of 43 · 852 trades